Stage II Ovarian Cancer AJCC v8

general

Stage IIIA includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. T3a: Ovarian cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No

65

Centers

73

Active Trials

$2.6B

Cancer Funding

Specific Cancer Types(2)

NameCenters
Stage IIA Ovarian Cancer45
Stage IIB Ovarian Cancer45

Top Centers for Stage II Ovarian Cancer AJCC v8(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
173.0
2
NCI Comprehensive
Active Research Program
66.6
3
NCI Comprehensive
Active Research Program
66.6
4
NCI Comprehensive
Active Research Program
66.6
5
NCI Comprehensive
Active Research Program
66.6
6
NCI Comprehensive
Active Research Program
66.6
7
Active Research Program
66.6
8
NCI Clinical
Active Research Program
66.6
9
NCI Comprehensive
Active Research Program
66.6
10
Active Research Program
66.6
11
NCI Clinical
Active Research Program
66.6
12
NCI Comprehensive
Active Research Program
66.6
13
Active Research Program
66.6
14
Active Research Program
66.6
15
Active Research Program
66.6
16
Active Research Program
66.6
17
NCI Comprehensive
Active Research Program
44.5
18
NCI Comprehensive
Active Research Program
44.5
19
NCI Comprehensive
Active Research Program
44.5
20
NCI Comprehensive
Active Research Program
44.5
21
NCI Comprehensive
Active Research Program
44.5
22
NCI Comprehensive
Active Research Program
44.5
23
NCI Comprehensive
Active Research Program
44.5
24
NCI Comprehensive
Active Research Program
44.5
25
NCI Comprehensive
Active Research Program
44.5
26
NCI Comprehensive
Active Research Program
44.5
27
NCI Comprehensive
Active Research Program
44.5
28
NCI Comprehensive
Active Research Program
44.5
29
NCI Comprehensive
Active Research Program
44.5
30
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.5
31
NCI Comprehensive
Active Research Program
44.5
32
NCI Comprehensive
Active Research Program
44.5
33
NCI Comprehensive
Active Research Program
44.5
34
NCI Comprehensive
Active Research Program
44.5
35
NCI Comprehensive
Active Research Program
44.5
36
NCI Comprehensive
Active Research Program
44.5
37
NCI Clinical
Active Research Program
44.5
38
NCI Comprehensive
Active Research Program
44.5
39
Active Research Program
44.5
40
NCI Comprehensive
Active Research Program
44.5
41
NCI Comprehensive
Active Research Program
44.5
42
NCI Comprehensive
Active Research Program
44.5
43
Active Research Program
44.5
44
Active Research Program
44.5
45
NCI Comprehensive
Active Research Program
44.5
4644.5
47
Active Research Program
44.5
48
Active Research Program
44.5
49
NCI Basic_laboratory
Active Research Program
44.5
50
Active Research Program
44.5
51
Active Research Program
44.5
5244.5
53
Active Research Program
44.5
54
Active Research Program
44.5
55
Active Research Program
44.5
56
Active Research Program
44.5
57
NCI Comprehensive
58
NCI Comprehensive
59
NCI Comprehensive
60
NCI Comprehensive
61
62
Cedars-Sinai CancerLos Angeles, CA
63
NCI Comprehensive
64
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
65
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →